Azafaros to Present Nizubaglustat Research at WORLDSymposium 2026
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its...
Tag : Azafaros
Azafaros Strengthens Board with Biotech Entrepreneur Appointment
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced the appointment...
Azafaros Raises €132M in Series B for Phase 3 Lysosomal Therapies
Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of...